Cristina Magi-Galluzzi

Author PubWeight™ 105.62‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Retracted Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog 2006 10.08
2 EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent. Science 2012 3.74
3 ALK-1 expression in inflammatory myofibroblastic tumor of the urinary bladder. Am J Surg Pathol 2004 3.08
4 Saturation technique does not improve cancer detection as an initial prostate biopsy strategy. J Urol 2006 3.02
5 Robotic real-time near infrared targeted fluorescence imaging in a murine model of prostate cancer: a feasibility study. Urology 2013 2.15
6 Renal angiomyolipoma: clinicopathologic study of 194 cases with emphasis on the epithelioid histology and tuberous sclerosis association. Am J Surg Pathol 2009 2.10
7 The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters. Am J Surg Pathol 2013 2.05
8 Adult cystic nephroma and mixed epithelial and stromal tumor of the kidney are the same disease entity: molecular and histologic evidence. Am J Surg Pathol 2009 1.84
9 Low testosterone and risk of biochemical recurrence and poorly differentiated prostate cancer at radical prostatectomy. Urology 2008 1.71
10 Analytical validation of the Oncotype DX prostate cancer assay - a clinical RT-PCR assay optimized for prostate needle biopsies. BMC Genomics 2013 1.70
11 Can saturation biopsy predict prostate cancer localization in radical prostatectomy specimens: a correlative study and implications for focal therapy. Urology 2010 1.58
12 Laparoscopic partial nephrectomy for cystic masses. J Urol 2005 1.49
13 Epithelial-to-mesenchymal transition in renal neoplasms. Adv Anat Pathol 2014 1.47
14 Local recurrence of prostate cancer in rectal submucosa after transrectal needle biopsy and radical prostatectomy. Urology 2005 1.38
15 Prostate cancer volume at biopsy predicts clinically significant upgrading. J Urol 2008 1.35
16 Continuing trends in pathological stage migration in radical prostatectomy specimens. Urol Oncol 2004 1.25
17 Phase II trial of neoadjuvant docetaxel before radical prostatectomy for locally advanced prostate cancer. Urology 2004 1.25
18 Renal neuroendocrine tumours: a clinicopathological study. BJU Int 2007 1.24
19 Adult cystic nephroma and mixed epithelial and stromal tumor of the kidney: clinical, radiographic, and pathologic characteristics. Urology 2008 1.20
20 The prognostic significance of tertiary Gleason pattern 5 in radical prostatectomy specimens. Am J Surg Pathol 2004 1.17
21 Pathologic stage migration has slowed in the late PSA era. Urology 2007 1.17
22 Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumors of the kidney. Am J Surg Pathol 2010 1.16
23 Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification. Am J Surg Pathol 2009 1.15
24 The usefulness of immunohistochemical markers in the differential diagnosis of renal neoplasms. Clin Lab Med 2005 1.14
25 A working group classification of focal prostate atrophy lesions. Am J Surg Pathol 2006 1.13
26 Importance of additional "extreme" anterior apical needle biopsies in the initial detection of prostate cancer. Urology 2010 1.11
27 Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients. Am J Surg Pathol 2014 1.11
28 Metanephric adenoma and solid variant of papillary renal cell carcinoma: common and distinctive features. Histopathology 2013 1.10
29 Dysregulation of cholesterol homeostasis in human prostate cancer through loss of ABCA1. Cancer Res 2012 1.10
30 The Epstein criteria predict for organ-confined but not insignificant disease and a high likelihood of cure at radical prostatectomy. Eur Urol 2009 1.08
31 Peritumoral lymphatic invasion is associated with regional lymph node metastases in prostate adenocarcinoma. Mod Pathol 2006 1.05
32 Saturation technique does not decrease cancer detection during followup after initial prostate biopsy. J Urol 2008 1.04
33 Real-time transrectal ultrasound guidance during laparoscopic radical prostatectomy: impact on surgical margins. J Urol 2006 1.04
34 ERG gene rearrangement status in prostate cancer detected by immunohistochemistry. Virchows Arch 2011 1.04
35 The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer. BJU Int 2007 1.02
36 Prostate cancer staging and grading at radical prostatectomy over time. Adv Anat Pathol 2011 1.02
37 ERG rearrangement is present in a subset of transition zone prostatic tumors. Mod Pathol 2010 1.01
38 Mucinous adenocarcinoma of the prostate does not confer poor prognosis. Urology 2006 0.97
39 PAX8 and PAX2 immunostaining facilitates the diagnosis of primary epithelial neoplasms of the male genital tract. Am J Surg Pathol 2011 0.96
40 ERG protein expression in human tumors detected with a rabbit monoclonal antibody. Am J Clin Pathol 2012 0.96
41 Laparoscopic extended pelvic lymphadenectomy for bladder cancer: technique and initial outcomes. J Urol 2004 0.95
42 Water jet assisted laparoscopic partial nephrectomy without hilar clamping in the calf model. J Urol 2005 0.95
43 Renal cell carcinomas with intratumoral fat and concomitant angiomyolipoma: potential pitfalls in staging and diagnosis. Am J Clin Pathol 2010 0.95
44 Metastatic papillary thyroid carcinoma to the kidney: report of two cases mimicking primary renal cell carcinoma and review of the literature. Pathology 2013 0.93
45 Differential expression of melanocytic markers in myoid, lipomatous, and vascular components of renal angiomyolipomas. Arch Pathol Lab Med 2007 0.93
46 ETS gene aberrations in atypical cribriform lesions of the prostate: Implications for the distinction between intraductal carcinoma of the prostate and cribriform high-grade prostatic intraepithelial neoplasia. Am J Surg Pathol 2010 0.93
47 Folate hydrolase (prostate-specific membrane [corrected] antigen) 1 expression in bladder cancer subtypes and associated tumor neovasculature. Mod Pathol 2011 0.93
48 Utility of PTEN and ERG immunostaining for distinguishing high-grade PIN from intraductal carcinoma of the prostate on needle biopsy. Am J Surg Pathol 2015 0.93
49 Atypical cribriform lesions of the prostate: relationship to prostatic carcinoma and implication for diagnosis in prostate biopsies. Am J Surg Pathol 2010 0.92
50 Discrepancy in prostate cancer localization between biopsy and prostatectomy specimens in patients with unilateral positive biopsy: implications for focal therapy. Prostate 2011 0.92
51 The diagnostic utility of novel immunohistochemical marker ERG in the workup of prostate biopsies with "atypical glands suspicious for cancer". Am J Surg Pathol 2011 0.92
52 Tumor volume does not predict for biochemical recurrence after radical prostatectomy in patients with surgical Gleason score 6 or less prostate cancer. Urology 2007 0.92
53 Grading of clear cell renal cell carcinoma should be based on nucleolar prominence. Am J Surg Pathol 2011 0.91
54 Non-small cell lung carcinoma metastatic to the kidney. Can J Urol 2006 0.91
55 The utility of ERG/P63 double immunohistochemical staining in the diagnosis of limited cancer in prostate needle biopsies. Am J Surg Pathol 2011 0.91
56 Incidence and clinicopathological characteristics of intraductal carcinoma detected in prostate biopsies: a prospective cohort study. Histopathology 2013 0.91
57 Fumarate Hydratase-deficient Renal Cell Carcinoma Is Strongly Correlated With Fumarate Hydratase Mutation and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome. Am J Surg Pathol 2016 0.91
58 Ductal adenocarcinoma of the prostate diagnosed on transurethral biopsy or resection is not always indicative of aggressive disease: implications for clinical management. BJU Int 2009 0.90
59 Hereditary syndromes with associated renal neoplasia: a practical guide to histologic recognition in renal tumor resection specimens. Adv Anat Pathol 2013 0.89
60 The prognostic significance of epidermal growth factor receptor expression in clear-cell renal cell carcinoma: a call for standardized methods for immunohistochemical evaluation. Clin Genitourin Cancer 2007 0.89
61 Potassium-titanyl-phosphate laser laparoscopic partial nephrectomy without hilar clamping in the survival calf model. J Urol 2005 0.89
62 Multifocal high grade prostatic intraepithelial neoplasia is a risk factor for subsequent prostate cancer. J Urol 2010 0.88
63 Clinical and biological effects of neoadjuvant sargramostim and thalidomide in patients with locally advanced prostate carcinoma. Clin Cancer Res 2008 0.88
64 Pathologic characteristics of solitary small renal masses: can they be predicted by preoperative clinical parameters? Am J Clin Pathol 2008 0.88
65 Single focus prostate cancer: pathological features and ERG fusion status. J Urol 2010 0.86
66 The distinction of bronchogenic cyst from metastatic testicular teratoma: a light microscopic and immunohistochemical study. Am J Clin Pathol 2008 0.86
67 Pathological aggressiveness of prostatic carcinomas related to RNASEL R462Q allelic variants. J Urol 2008 0.85
68 Prostate cancer patients older than 70 years treated by radical prostatectomy have higher biochemical recurrence rate than their matched younger counterpart. Prostate 2012 0.85
69 Tuberous sclerosis-associated renal cell carcinoma: a clinicopathologic study of 57 separate carcinomas in 18 patients. Am J Surg Pathol 2014 0.85
70 Autophagic flux determines cell death and survival in response to Apo2L/TRAIL (dulanermin). Mol Cancer 2014 0.84
71 Rhabdoid differentiation is associated with aggressive behavior in renal cell carcinoma: a clinicopathologic analysis of 76 cases with clinical follow-up. Am J Surg Pathol 2014 0.83
72 Metastatic prostate adenocarcinoma to the penis presenting as pagetoid carcinoma: a phenomenon not previously reported. Am J Surg Pathol 2015 0.83
73 Renal leiomyoma: a contemporary multi-institution study of an infrequent and frequently misclassified neoplasm. Am J Surg Pathol 2015 0.83
74 Intraductal carcinoma of the prostate: precursor or aggressive phenotype of prostate cancer? Prostate 2012 0.83
75 Diagnostic criteria for ductal adenocarcinoma of the prostate: interobserver variability among 20 expert uropathologists. Histopathology 2014 0.81
76 Intraductal carcinoma of the prostate. Arch Pathol Lab Med 2012 0.81
77 Tubulocystic Carcinoma of the Kidney With Poorly Differentiated Foci: A Frequent Morphologic Pattern of Fumarate Hydratase-deficient Renal Cell Carcinoma. Am J Surg Pathol 2016 0.80
78 Expression of ERG protein, a prostate cancer specific marker, in high grade prostatic intraepithelial neoplasia (HGPIN): lack of utility to stratify cancer risks associated with HGPIN. BJU Int 2012 0.80
79 Eosinophilic, Solid, and Cystic Renal Cell Carcinoma: Clinicopathologic Study of 16 Unique, Sporadic Neoplasms Occurring in Women. Am J Surg Pathol 2016 0.80
80 Laser robotically assisted nerve-sparing radical prostatectomy: a pilot study of technical feasibility in the canine model. BJU Int 2008 0.79
81 KTP laser nerve sparing radical prostatectomy: comparison of ultrasonic and cold scissor dissection on cavernous nerve function. J Urol 2009 0.79
82 Diagnosis of "Poorly Formed Glands" Gleason Pattern 4 Prostatic Adenocarcinoma on Needle Biopsy: An Interobserver Reproducibility Study Among Urologic Pathologists With Recommendations. Am J Surg Pathol 2015 0.78
83 Predictors of lymph node metastasis in T1 breast carcinoma, stratified by patient age. Breast J 2002 0.78
84 Preoperative PSA is still predictive of cancer volume and grade in late PSA era. Urology 2007 0.77
85 Adenomatoid tumour of the adrenal gland in a patient with germline SDHD mutation: a case report and review of the literature. Pathology 2011 0.77
86 ERG protein expression as a biomarker of prostate cancer. Biomark Med 2013 0.77
87 Are prostate needle biopsies predictive of the laterality of significant cancer and positive surgical margins? BJU Int 2009 0.77
88 Targeted Contrast Agent Specific to an Oncoprotein in Tumor Microenvironment with the Potential for Detection and Risk Stratification of Prostate Cancer with MRI. Bioconjug Chem 2017 0.76
89 Editorial comment. J Urol 2010 0.75
90 Cadherin 17 is a sensitive and specific marker for metanephric adenoma. Am J Surg Pathol 2015 0.75
91 A 45-year-old with neuroendocrine carcinoma of the prostate. Urology 2013 0.75
92 Renal Cell Carcinoma Occurring in Patients With Prior Neuroblastoma: A Heterogenous Group of Neoplasms. Am J Surg Pathol 2016 0.75
93 Microscopic bladder neck involvement by prostate carcinoma in radical prostatectomy specimens is not a significant independent prognostic factor. Mod Pathol 2008 0.75
94 Pathology update for urologists. Prostate Cancer 2011 0.75
95 Tumor Necrosis Adds Prognostically Significant Information to Grade in Clear Cell Renal Cell Carcinoma: A Study of 842 Consecutive Cases From a Single Institution. Am J Surg Pathol 2016 0.75
96 PTEN Expression in Mucinous Prostatic Adenocarcinoma, Prostatic Adenocarcinoma With Mucinous Features, and Adjacent Conventional Prostatic Adenocarcinoma: A Multiinstitutional Study of 92 Cases. Appl Immunohistochem Mol Morphol 2016 0.75
97 Clinicopathological features of prostate cancers detected after an initial diagnosis of 'atypical glands suspicious for cancer'. Pathology 2010 0.75
98 Prostate basal cell lesions can be negative for basal cell keratins: a diagnostic pitfall. Anal Quant Cytol Histol 2006 0.75
99 Synchronized real-time ultrasonography and three-dimensional computed tomography scan navigation during percutaneous renal cryoablation in a porcine model. J Endourol 2010 0.75
100 Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution. Am J Surg Pathol 2016 0.75